Click Here to Read: The Medium Is the Medium By David Brooks in the New York Times on July 8, 2010.
Category: Editorials
A nation under post-traumatic stress
Now Don’t Hear This
Click Here to Read: Now Don’t Hear This by George Prochnik, OpEd Article in the New York Times on May 1, 2010.
George Prochnik is the author of Putnam Camp: Sigmund Freud, James Jackson Putnam, and the Purpose of American Psychology.
Click Here to Read: Reviews of Putnam Camp on this website.
George Prochnik
Finding Psychoanalytic Values in Unexpected Places
Op-Eds on Children and Medication by Claudia Meninger Gold
Click Here To Read: Mind-altering drugs and the problem child By Claudia Meininger Gold in the Boston Globe on June 30, 2008.
Click Here to Read: Medication can’t fix a broken childhood By Claudia Meininger Gold in the Boston Globe on January 26, 2009.
Click Here to Read: Backed into a treatment corner By Claudia Gold in the Boston Globe on March 30, 2009
Click Here To Read: In autism, medication is only a partial answer by Claudia M. Gold in the Boston Globe on December 14, 2009.
A dose of common sense: U.S.-style health care involves a lot of costly procedures, but not enough thought
Freud’s Adirondack Vacation
Click Here ro Read: Freud’s Adirondack Vacation by Leon Hoffman, OpEd Contributor, in the New York Times on August 29, 2009.
Click Here To Read: Putnam Camp : Sigmund Freud, James Jackson Putnam, and the Purpose of American Psychology By George Prochnik, Reviewed By Arnold Richards.
Click Here To Read: Adirondack Couch by Peter D. Kramer in the New York Times on December 24, 2006.
Leon Hoffman
Obama’s Style Problem as Procedural Memory
Reframing the Relationship of Psychoanalysis and Neuroscience
Brain Gain: The underground world of “neuroenhancing” drugs
Click Here To Read: Brain Gain: The underground world of “neuroenhancing” drugs by Margaret Talbot in the New Yorker on April 27, 2009.
Click Here To Read: Leon Hoffman’s Letter to the editor about Brain Gain: The underground world of “neuroenhancing” drugs.
Every era has its defining drug. Neuroenhancers are perfectly suited for our efficiency-obsessed, BlackBerry-equipped office culture.